HeyJaredThe GLP-1 Podcast Show
A whole new era of communication in GLP-1 is here!----------------------------------------------------Now you’ve got the sharpest minds in GLP-1 research right in your pocket.
- Indexed episodes, last 90 days
- 4
- Latest publication
- Sep 7, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 6, 2026
Latest episodes
Dr. Ashley Koff: Weight Health in the GLP-1 Era | Ep. 13 (opens the original)
Read excerpt
In this episode of The GLP-1 Podcast Show, I speak with Dr. Ashley Koff, registered dietitian, founder of The Better Nutrition Program, and bestselling author of Your Best Shot, about weight health in the GLP-1 era. She explains why body composition matters more than total weight, how digestion and hydration shape nutrition outcomes, why protein advice must be personalized, and how clinicians can support more sustainable metabolic health. Listen now on all major platforms. "Weight composition, i
Dr. Timothy Garvey: Adiposity-Based Chronic Disease Explained | Ep. 12 (opens the original)
Read excerpt
In this episode of The GLP-1 Podcast Show, I speak with Dr. Timothy Garvey, Endowed Professor of Medicine at the University of Alabama at Birmingham, about complication-centric care for Adiposity-Based Chronic Disease. We examine current obesity guidelines, medication selection according to complications, what the key unmet clinical need is in obesity care, and the role of second-generation GLP-1 medications in type 2 diabetes. Listen now on all major platforms. "Obesity treatment should focus o
Dr. Christopher Kramer: Tirzepatide And Cardiovascular Health | Ep. 11 (opens the original)
Read excerpt
In this episode of The GLP-1 Podcast Show, I speak with Dr. Christopher Kramer, Chief of the Cardiovascular Division at the University of Virginia Health, about how GLP-1 and GIP therapies are reshaping the treatment of obesity-related heart failure. We explore cardiac remodeling, adipose tissue reduction, cardiovascular outcomes, and the mechanisms behind improved patient health. Listen now on all major platforms! "Treatment with tirzepatide reduced heart failure events by approximately fifty p
Dr. Richard DiMarchi: The Evolution of GLP-1 Science | Ep. 10 (opens the original)
Read excerpt
In this episode of The GLP-1 Podcast Show, I speak with Dr. Richard DiMarchi, Distinguished Professor at Indiana University and a pioneer in peptide therapeutics, about the scientific journey behind GLP-1 therapies, multiagonist drug development, and future obesity treatments. We explore glucagon, GIP, triple agonists, and emerging innovations shaping metabolic medicine. Listen now on all major platforms! "For decades, glucagon was viewed primarily as a hormone that raises blood glucose. Researc
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.